Barclays
AHCO icon

Barclays’s AdaptHealth AHCO Stock Holding History

Barclays’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
19,819
-140,128
-88% -$1.43M ﹤0.01% 3594
2025
Q4 		$1.59M Buy
159,947
+16,451
+11% +$157K ﹤0.01% 3093
2025
Q3 		$1.28M Sell
143,496
-28,671
-17% -$266K ﹤0.01% 3213
2025
Q2 		$1.62M Buy
172,167
+36,310
+27% +$320K ﹤0.01% 3012
2025
Q1 		$1.47M Sell
135,857
-43,816
-24% -$441K ﹤0.01% 2870
2024
Q4 		$1.71M Sell
179,673
-1,567
-0.9% -$15.9K ﹤0.01% 3009
2024
Q3 		$2.04M Buy
181,240
+141,949
+361% +$1.51M ﹤0.01% 2826
2024
Q2 		$393K Sell
39,291
-42,796
-52% -$435K ﹤0.01% 3194
2024
Q1 		$945K Sell
82,087
-65,518
-44% -$557K ﹤0.01% 3163
2023
Q4 		$1.08M Buy
147,605
+105,477
+250% +$832K ﹤0.01% 3389
2023
Q3 		$383K Sell
42,128
-16,346
-28% -$196K ﹤0.01% 2948
2023
Q2 		$712K Buy
58,474
+6,657
+13% +$74.2K ﹤0.01% 2532
2023
Q1 		$644K Buy
51,817
+9,665
+23% +$178K ﹤0.01% 3081
2022
Q4 		$810K Sell
42,152
-149,123
-78% -$3.15M ﹤0.01% 2972
2022
Q3 		$3.59M Buy
191,275
+176,193
+1,168% +$3.62M ﹤0.01% 1365
2022
Q2 		$271K Sell
15,082
-9,070
-38% -$147K ﹤0.01% 3263
2022
Q1 		$386K Buy
+24,152
New +$434K ﹤0.01% 3064

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's AHCO Position: Q1 2026 in Review

Barclays reduced its AdaptHealth (AHCO) stake by 88% in Q1 2026, selling an estimated $1.43M and leaving 19,819 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

Barclays first reported a position in AHCO in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.59M in Q3 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Barclays held 19,819 shares of AdaptHealth worth $236K as of Q1 2026.
  • Barclays sold 140,128 AdaptHealth shares in Q1 2026, an estimated $1.43M.
  • AdaptHealth made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3594 holding.
  • Barclays first reported a position in AdaptHealth in Q1 2022 and has held it in 17 quarters since.
  • Barclays's AdaptHealth position peaked at $3.59M in Q3 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.